NL-OMON24067Other不适用
Pilot to validate in vivo 2-HG MR spectroscopy in low grade gliomas
适应症
试验速览
- 阶段
- 不适用
- 状态
- Other
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients with a low grade glioma ≥ 18 years that are planned to undergo surgery
排除标准
- •- Patients with recent cerebral radiotherapy or operation (<3 months).
- •- Age <18 years.
研究者
相似试验
进行中（未招募）
1 期
A study to find and investigate a safe dose of BI 836858 in combination with decitabine for patients with acute myeloid leukemia (AML)patients with acute myeloid leukemiaMedDRA version: 19.1Level: LLTClassification code 10000886Term: Acute myeloid leukemiaSystem Organ Class: 100000004864EUCTR2015-002892-30-ESBoehringer Ingelheim España, S.A.200
进行中（未招募）
1 期
A study to find and investigate a safe dose of BI 836858 in combination with decitabine for patients with acute myeloid leukemia (AML)patients with acute myeloid leukemiaMedDRA version: 21.0Level: LLTClassification code 10000886Term: Acute myeloid leukemiaSystem Organ Class: 100000004864EUCTR2015-002892-30-ITBOEHRINGER-INGELHEIM ITALIA S.P.A.200
进行中（未招募）
1 期
A study to find and investigate a safe dose of BI 836858 in combination with decitabine for patients with acute myeloid leukemia (AML)patients with acute myeloid leukemiaMedDRA version: 20.0Level: LLTClassification code 10000886Term: Acute myeloid leukemiaSystem Organ Class: 100000004864EUCTR2015-002892-30-DEBoehringer Ingelheim Pharma GmbH & Co. KG220
进行中（未招募）
1 期
Dose Escalation of DF1001 in Patients With Advanced Solid Tumors, and Expansion in Selected Indicationsocally Advanced or Metastatic Solid Tumors, and Expansion in Selected IndicationsMedDRA version: 21.1Level: LLTClassification code 10065252Term: Solid tumorSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: HLGTClassification code 10027476Term: MetastasesSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2019-004706-10-BEDragonfly Therapeutics, Inc.358
招募中
2 期
Dose Escalation of DF1001 in Patients With Advanced Solid Tumors, and Expansion in Selected Indications2023-503291-24-00Dragonfly Therapeutics Inc.174